DEA schedule
Is quetiapine a controlled substance?
Federal schedule for quetiapine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Quetiapine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and quetiapine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted quetiapine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 349 prescription listings from 52 labelers, none with a DEA schedule |
| DEA controlled substances list | quetiapine is not on the list |
Quetiapine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0310-0281 | SEROQUEL XR | tablet, extended release | 150 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-271 | SEROQUEL XR | tablet, extended release | 150 mg/1 | H2-Pharma, LLC | None |
| 0310-0282 | SEROQUEL XR | tablet, extended release | 200 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-272 | SEROQUEL XR | tablet, extended release | 200 mg/1 | H2-Pharma, LLC | None |
| 0310-0283 | SEROQUEL XR | tablet, extended release | 300 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-273 | SEROQUEL XR | tablet, extended release | 300 mg/1 | H2-Pharma, LLC | None |
| 0310-0284 | SEROQUEL XR | tablet, extended release | 400 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-274 | SEROQUEL XR | tablet, extended release | 400 mg/1 | H2-Pharma, LLC | None |
| 61269-270 | SEROQUEL XR | tablet, extended release | 50 mg/1 | H2-Pharma, LLC | None |
| 0310-0271 | SEROQUEL | tablet, film coated | 100 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-252 | SEROQUEL | tablet, film coated | 100 mg/1 | H2-Pharma, LLC | None |
| 0310-0272 | SEROQUEL | tablet, film coated | 200 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-253 | SEROQUEL | tablet, film coated | 200 mg/1 | H2-Pharma, LLC | None |
| 0310-0275 | SEROQUEL | tablet, film coated | 25 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-250 | SEROQUEL | tablet, film coated | 25 mg/1 | H2-Pharma, LLC | None |
| 0310-0274 | SEROQUEL | tablet, film coated | 300 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-254 | SEROQUEL | tablet, film coated | 300 mg/1 | H2-Pharma, LLC | None |
| 0310-0279 | SEROQUEL | tablet, film coated | 400 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-255 | SEROQUEL | tablet, film coated | 400 mg/1 | H2-Pharma, LLC | None |
| 0310-0278 | SEROQUEL | tablet, film coated | 50 mg/1 | AstraZeneca Pharmaceuticals LP | None |
| 61269-251 | SEROQUEL | tablet, film coated | 50 mg/1 | H2-Pharma, LLC | None |
| 43547-520 | QUETIAPINE | tablet | 100 mg/1 | Solco Healthcare US, LLC | None |
| 43547-521 | QUETIAPINE | tablet | 200 mg/1 | Solco Healthcare US, LLC | None |
| 43547-518 | QUETIAPINE | tablet | 25 mg/1 | Solco Healthcare US, LLC | None |
| 43547-522 | QUETIAPINE | tablet | 300 mg/1 | Solco Healthcare US, LLC | None |
| 43547-523 | QUETIAPINE | tablet | 400 mg/1 | Solco Healthcare US, LLC | None |
| 43547-519 | QUETIAPINE | tablet | 50 mg/1 | Solco Healthcare US, LLC | None |
| 29300-309 | Quetiapine | tablet, extended release | 150 mg/1 | Unichem Pharmaceuticals (USA), Inc. | None |
| 33342-134 | QUETIAPINE | tablet, extended release | 150 mg/1 | Macleods Pharmaceuticals Limited | None |
| 43547-020 | QUETIAPINE | tablet, extended release | 150 mg/1 | Solco Healthcare U.S., LLC | None |
| 68001-599 | Quetiapine | tablet, extended release | 150 mg/1 | BluePoint Laboratories | None |
| 29300-310 | Quetiapine | tablet, extended release | 200 mg/1 | Unichem Pharmaceuticals (USA), Inc. | None |
| 33342-135 | QUETIAPINE | tablet, extended release | 200 mg/1 | Macleods Pharmaceuticals Limited | None |
| 43547-021 | QUETIAPINE | tablet, extended release | 200 mg/1 | Solco Healthcare U.S., LLC | None |
| 67046-1623 | Quetiapine | tablet, extended release | 200 mg/1 | Coupler LLC | None |
| 68001-600 | Quetiapine | tablet, extended release | 200 mg/1 | BluePoint Laboratories | None |
| 70518-4699 | QUETIAPINE | tablet, extended release | 200 mg/1 | REMEDYREPACK INC. | None |
| 29300-311 | Quetiapine | tablet, extended release | 300 mg/1 | Unichem Pharmaceuticals (USA), Inc. | None |
| 33342-136 | QUETIAPINE | tablet, extended release | 300 mg/1 | Macleods Pharmaceuticals Limited | None |
| 43547-022 | QUETIAPINE | tablet, extended release | 300 mg/1 | Solco Healthcare U.S., LLC | None |
Showing 40 of 349 listings.
Questions
Is quetiapine a controlled substance?
No. Quetiapine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and quetiapine is not on the DEA controlled substances list.
Is quetiapine a narcotic?
No. Quetiapine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Atypical Antipsychotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Quetiapine
- What is Quetiapine used for?FDA label uses
- Generic for Seroquel XRFDA Orange Book
- Generic for SeroquelFDA Orange Book
- What is Seroquel used for?FDA label uses
- Is Seroquel a controlled substance?Federal schedule
- Atypical Antipsychotics listFDA drug class
- NDC 0310-0271Quetiapine NDC record
- NDC 0310-0272Quetiapine NDC record
- NDC 0310-0274Quetiapine NDC record